ACOGF - Alpha Cognition to Present at the Life Science Investor Forum March 7th | Benzinga
VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- Alpha Cognition, Inc. (CSE:ACOG)(OTCQB:ACOGF), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced that Michael McFadden, Chief Executive Officer, and Lauren D'Angelo, Chief Operating Officer, will present live at the Life Science Investor Forum, hosted by VirtualInvestorConferences.com, on March 7th, 2024. Mr. McFadden and Ms. D'Angelo will provide an overview of the Company's business, highlighting the Company's lead asset, ALPHA-1062 for mild-to-moderate Alzheimer's disease, during the presentation.
DATE: March 7, 2024
TIME: 12:30 PM ET
LINK: https://bit.ly/3OM3m93
Available for 1x1 meetings: March 7th, 8th, 11th and 12th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after ...